Stocks
Agios Pharmaceuticals (AGIO) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -61.9% | -83.9% | 124.2% | -6.77% | -43.4% | 41.5% | ||
| Changes by years, y/y, % | -12pp | -22pp | +208pp | -131pp | -37pp | -2.9% | |||
Agios Pharmaceuticals. ROE, %
Agios Pharmaceuticals. ROE, changes, pp
Agios Pharmaceuticals (AGIO) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -8.38% | -42.2% | -47.4% | -55.2% | 41.5% | 41.5% | |
| Changes by years, y/y, % | +25pp | -35pp | -42pp | -50pp | +50pp | |||
| Changes by quarters, q/q, % | -3pp | -34pp | -5pp | -8pp | +97pp | |||
